Bell Potter Securities is one of Australia’s largest full service stockbrokers and a leading financial advisory firm. The company was established in 1970 and provides comprehensive financial services to individuals, institutions and corporations with more than $37 billion in funds under advice. Bell Potter is a part of the Bell Financial Group (ASX:BFG), an Australian-owned company with a track record of growth and profitability. Dr Anubhav Saxena, Healthcare Equities Analyst at Bell Potter, has conducted and released in-depth research into Australia’s biotech and medicinal cannabis industries and has helped facilitate successful buy-recommendations for companies operating within both industries.

Merchant Funds Management is a boutique funds manager with a reputation as one of the leading biotech investors in Australia. The manager’s recently launched Merchant Biotech Fund focuses on emerging medtech, biotech, health and life science industries while its longstanding Merchant Opportunities Fund has outperformed the ASX by more than 23 percentage points in the seven-year period up to 30th June 2022. Andrew Chapman, Managing Director of Merchant Funds Management, has market-tested knowledge on active portfolio management and risk. His objective is to take the expertise he has gained over 20-plus years of managing the investments of the uber-wealthy and work to make those opportunities available to all.

Wellnex Life Limited is a Australian health and wellness consumer business that specialises in manufacturing, licensing and taking brands to market. Listed in 2021, the company has grown quickly, launching and licensing five cutting-edge full-owned brands, gaining key knowledge of regulatory approval processes and establishing partnerships and agreements with leading companies in the Australian and global health and wellness space. With key competencies in identifying key growth areas in the market, Wellnex Life is focused on building a portfolio of brands and businesses that addresses consumer needs ‘first and fast’ to propel the company forward and create value for shareholders.